An experimental mRNA cancer vaccine shows promising results in a Phase 1 trial, potentially offering new hope for advanced-stage cancer patients.
Vous n'êtes pas connecté
Promising results from nipocalimab drug trial for a rare fetal blood disease suggest a less invasive treatment, offering new hope for affected families.
An experimental mRNA cancer vaccine shows promising results in a Phase 1 trial, potentially offering new hope for advanced-stage cancer patients.
Millions of people worldwide suffer from liver inflammation (hepatitis), which can be caused by various factors, including metabolic disorders like...
Millions of people worldwide suffer from liver inflammation (hepatitis), which can be caused by various factors, including metabolic disorders like...
RNA nasal spray: A groundbreaking innovation in treating memory loss and anxiety, offering new hope for more effective and non-invasive therapies.
A recent study from the University of Bristol has uncovered a promising new method to slow the progression of diabetic kidney disease, a condition...
Experts hail ‘remarkable’ trial results for treatment of a form of skin cancer that once had grim prognosis
Relief Therapeutics Holding SA, a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare...
A chronic inflammatory disorder of the gastrointestinal (GI) tract, inflammatory bowel disease (IBD) includes Crohn's disease (CD) and...
by Kavitha SuranaProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one...
Rare diseases affect fewer than 1 in 2,000 people individually. However, with over 7,000 different types identified, their global impact is...